Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.

Avenue Capital Group

Saturn Partners

Third Pole Therapeutics

Third Pole is a company that has developed an investigational device that uses proprietary technology to produce pure Nitric Oxide (NO) for inhalation on-demand from air, enabling bedside and portable therapeutic use.

COM:POLE3

Third Pole

Filings Not Available